OBJECTIVE: In synovial fluid (SF) from patients with rheumatoid arthritis (RA), neutrophils are exposed to proinflammatory mediators endowed with either anti-apoptotic or pro-apoptotic properties. We investigated neutrophil apoptosis in the presence of SF from 11 RA patients. METHODS: SF was obtained from affected knees of 11 patients with RA. Human neutrophil apoptosis was evaluated by light microscopic examination and flow-cytometric analysis of annexin V binding. Immune complex-induced neutrophil activation was evaluated as superoxide anion production. Adenosine levels in SF were detected by chromatographic analysis and cytokine levels were studied by enzyme-linked immunosorbent assay. RESULTS: Spontaneous and immune complex-triggered neutrophil apoptosis was reduced by SF from eight out of 11 patients. Immune complex-induced neutrophil activation was unaffected by SF. The cytokines tested had no role in promoting the anti-apoptotic activity of SF. On the contrary, the anti-apoptotic activity of SF was found to depend on the presence of adenosine. Adenosine levels detected in the various samples of SF correlated significantly with the anti-apoptotic activity of the fluids and with the number of apoptotic neutrophils detected in the articular exudate. CONCLUSION: The microenvironment of rheumatoid SF is a proinflammatory milieu responsible for the in loco persistence of activated and long-surviving neutrophils. Adenosine plays a crucial role in this phenomenon, which is related to anti-apoptotic activity.
OBJECTIVE: In synovial fluid (SF) from patients with rheumatoid arthritis (RA), neutrophils are exposed to proinflammatory mediators endowed with either anti-apoptotic or pro-apoptotic properties. We investigated neutrophil apoptosis in the presence of SF from 11 RApatients. METHODS: SF was obtained from affected knees of 11 patients with RA. Human neutrophil apoptosis was evaluated by light microscopic examination and flow-cytometric analysis of annexin V binding. Immune complex-induced neutrophil activation was evaluated as superoxide anion production. Adenosine levels in SF were detected by chromatographic analysis and cytokine levels were studied by enzyme-linked immunosorbent assay. RESULTS: Spontaneous and immune complex-triggered neutrophil apoptosis was reduced by SF from eight out of 11 patients. Immune complex-induced neutrophil activation was unaffected by SF. The cytokines tested had no role in promoting the anti-apoptotic activity of SF. On the contrary, the anti-apoptotic activity of SF was found to depend on the presence of adenosine. Adenosine levels detected in the various samples of SF correlated significantly with the anti-apoptotic activity of the fluids and with the number of apoptotic neutrophils detected in the articular exudate. CONCLUSION: The microenvironment of rheumatoid SF is a proinflammatory milieu responsible for the in loco persistence of activated and long-surviving neutrophils. Adenosine plays a crucial role in this phenomenon, which is related to anti-apoptotic activity.
Authors: Anne-Claire Duchez; Luc H Boudreau; Gajendra S Naika; James Bollinger; Clémence Belleannée; Nathalie Cloutier; Benoit Laffont; Raifish E Mendoza-Villarroel; Tania Lévesque; Emmanuelle Rollet-Labelle; Matthieu Rousseau; Isabelle Allaeys; Jacques J Tremblay; Patrice E Poubelle; Gérard Lambeau; Marc Pouliot; Patrick Provost; Denis Soulet; Michael H Gelb; Eric Boilard Journal: Proc Natl Acad Sci U S A Date: 2015-06-23 Impact factor: 11.205
Authors: Yanni Wang; Christy A Thomson; Lenka L Allan; Linda M Jackson; Melanie Olson; Timothy R Hercus; Tracy L Nero; Amanda Turner; Michael W Parker; Angel L Lopez; Thomas K Waddell; Gary P Anderson; John A Hamilton; John W Schrader Journal: Proc Natl Acad Sci U S A Date: 2013-04-25 Impact factor: 11.205
Authors: Debra M Meyer; Michael I Jesson; Xiong Li; Mollisa M Elrick; Christie L Funckes-Shippy; James D Warner; Cindy J Gross; Martin E Dowty; Shashi K Ramaiah; Jeffrey L Hirsch; Matthew J Saabye; Jennifer L Barks; Nandini Kishore; Dale L Morris Journal: J Inflamm (Lond) Date: 2010-08-11 Impact factor: 4.981
Authors: R R Minter; E S Cohen; B Wang; M Liang; I Vainshtein; G Rees; L Eghobamien; P Harrison; D A Sims; C Matthews; T Wilkinson; P Monk; C Drinkwater; L Fabri; A Nash; M McCourt; L Jermutus; L Roskos; I K Anderson; M A Sleeman Journal: Br J Pharmacol Date: 2013-01 Impact factor: 8.739
Authors: S H Wong; N Francis; H Chahal; K Raza; M Salmon; D Scheel-Toellner; J M Lord Journal: Rheumatology (Oxford) Date: 2008-11-23 Impact factor: 7.580